SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 4)

Oscar Health, Inc.

(Name of Issuer)

Class A Common Stock, $0.00001 par value per share

(Title of Class of Securities)

687793109

(CUSIP Number)

Jed Feldman
c/o Thrive Capital, 295 Lafayette Street, 7th Fl.
New York, NY, 10012
646-680-0240

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

09/18/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Capital Partners II, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 4,779,730.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,779,730.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

4,779,730.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

1.7 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Partners II GP, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 4,779,730.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,779,730.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

4,779,730.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

1.7 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Capital Partners III, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 17,535,258.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 17,535,258.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

17,535,258.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

6.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Claremount TW, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 593,021.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 593,021.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

593,021.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.2 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Partners III GP, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 18,128,279.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 18,128,279.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

18,128,279.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

6.2 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Capital Partners V, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,040,704.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,040,704.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

1,040,704.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.4 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Claremount V Associates, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 19,239.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 19,239.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

19,239.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Partners V GP, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,059,943.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,059,943.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

1,059,943.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.4 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Capital Partners VI Growth, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 2,498,513.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 2,498,513.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

2,498,513.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.9 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Claremount VI Associates, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 48,982.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 48,982.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

48,982.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Partners VI GP, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 2,547,495.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 2,547,495.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

2,547,495.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.9 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Capital Partners VII Growth, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 10,424,005.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 10,424,005.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

10,424,005.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

3.7 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Partners VII Growth GP, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 10,424,005.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 10,424,005.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

10,424,005.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

3.7 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Claremount VII Associates, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 125,632.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 125,632.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

125,632.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Thrive Partners VII GP, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 125,632.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 125,632.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

125,632.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

687793109

Name of reporting person

Joshua Kushner

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 37,525,451.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 37,525,451.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

37,525,451.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

12.1 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Class A Common Stock, $0.00001 par value per share

(b)

Name of Issuer:

Oscar Health, Inc.

(c)

Address of Issuer's Principal Executive Offices:

75 VARICK STREET, 5TH FLOOR, NEW YORK, NEW YORK , 10013.

Item 1 Comment:

This Amendment No. 4 (this "Amendment") amends and supplements the Schedule 13D (the "Schedule 13D") filed by the Reporting Persons on August 30, 2021, as amended, with respect to the Class A common stock, $0.00001 par value per share (the "Class A Common Stock"), of Oscar Health, Inc. (the "Company" or the "Issuer"). The Issuer also has Class B common stock, $0.00001 par value per share (the "Class B Common Stock" and together with the Class A Common Stock, the "Common Stock"), issued and outstanding. Each share of Class A Common Stock is entitled to one vote per share. Each share of Class B Common Stock is entitled to 20 votes per share and is convertible at the election of the holder into one share of Class A Common Stock. In addition, each share of Class B Common Stock will be automatically converted into one share of Class A Common Stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering or upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Item 5.

Interest in Securities of the Issuer

(a)

The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated by reference. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the percent of class was calculated based on (i) 273,469,000 shares of Class A Common Stock outstanding as of July 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q as filed by the Issuer with the SEC on August 7, 2026, (ii) the shares, if any, of Class A Common Stock underlying Convertible Notes beneficially owned by the reporting person and (iii) the shares, if any, of Class B Common Stock of the Issuer beneficially owned by the reporting person (with such shares treated as converted into shares of Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to the Exchange Act). Thrive Capital Partners II, L.P. ("Thrive II") directly holds 4,779,730 shares of Class B common stock. Thrive Partners II GP, LLC ("Thrive Partners II"), as the general partner of Thrive II, may be deemed to beneficially own the shares directly held Thrive II. Thrive Capital Partners III, L.P. ("Thrive III") directly holds 17,535,258 shares of Class B common stock and Claremount TW, L.P. ("Claremount TW") directly holds 593,021 shares of Class B common stock. Thrive Partners III GP, LLC ("Thrive Partners III"), as the general partner of Thrive III and Claremount TW, may be deemed to beneficially own the shares directly held Thrive III and Claremount TW. Thrive Capital Partners V, L.P. ("Thrive V") directly holds 1,040,704 shares of Class B common stock and Claremount V Associates, L.P. ("Claremount V") directly holds 19,239 shares of Class B common stock. Thrive Partners V GP, LLC ("Thrive Partners V"), as the general partner of Thrive V and Claremount V, may be deemed to beneficially own the shares directly held Thrive V and Claremount V. Thrive Capital Partners VI Growth, L.P. ("Thrive VI Growth") directly holds 2,498,513 shares of Class B common stock and Claremount VI Associates, L.P. ("Claremount VI") directly holds 48,982 shares of Class B common stock. Thrive Partners VI GP, LLC ("Thrive Partners VI"), as the general partner of Thrive VI Growth and Claremount VI, may be deemed to beneficially own the shares directly held Thrive VI Growth and Claremount VI. Thrive VII Growth directly holds 6,268,097 shares of Class B common stock and, subject to the terms of conversion applicable to the Convertible Notes set forth in the Indenture (as previously described in Item 6 of this statement), may be deemed to beneficially own 4,155,908 shares of Class A common stock issuable upon conversion of the outstanding principal of Convertible Notes at the current Conversion Rate (as defined in the Indenture). Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth"), as the general partner of Thrive VII Growth, may be deemed to beneficially own the shares directly held and/or beneficially owned by Thrive VII Growth. Claremount VII (together with Thrive II, Thrive III, Thrive V, Thrive VI Growth, Claremount TW, Claremount V, Claremount VI and Thrive VII Growth, the "Thrive Capital Funds") directly holds 75,520 shares of Class B common stock and, subject to the terms of conversion applicable to the Convertible Notes set forth in the Indenture, may be deemed to beneficially own 50,112 shares of Class A common stock issuable upon conversion of the outstanding principal of Convertible Notes at the current Conversion Rate (as defined in the Indenture). Thrive Partners VII GP, LLC ("Thrive Partners VII" and together with Thrive Partners II, Thrive Partners III, Thrive Partners V, Thrive Partners VI and Thrive Partners VII Growth, the "Thrive General Partners"), as the general partner of Claremount VII, may be deemed to beneficially own the shares directly held and/or beneficially owned by Claremount VII. Mr. Kushner directly owns 460,367 shares of Class A Common Stock. In addition, as the sole managing member of each of the Thrive General Partners, Mr. Kushner may be deemed to beneficially own the Shares held and/or beneficially owned by the Thrive Capital Funds.

(b)

The information reported in Item 5(a) is incorporated by reference herein.

(c)

On September 18, 2026, (i) Thrive II transferred 1,307,831 and 15,758 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 1,307,831 and 15,758 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (ii) Thrive III transferred 4,798,003 and 57,807 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 4,798,003 and 57,807 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (iii) Claremount TW transferred 162,263 and 1,955 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 162,263 and 1,955 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively. Subsequently, on the same date, (i) Thrive II distributed to its limited partners and sole general partner, pro rata and without consideration, 1,323,589 shares of Class A Common Stock; (ii) Thrive III distributed to its limited partners and sole general partner, pro rata and without consideration, 4,855,810 shares of Class A Common Stock; and (iii) Claremount TW distributed to its limited partners and sole general partner, pro rata and without consideration, 164,218 shares of Class A Common Stock. Each of Thrive Partners II GP, LLC and Thrive Partners III GP, LLC, in turn, distributed to their members, pro rata and without consideration, the shares of Class A Common Stock received in the foregoing distributions. Except as described herein, none of the reporting persons has effected any transactions in the Issuer's Class A Common Stock during the last 60 days.

(d)

Except as described herein, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities covered by this statement.

(e)

Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Thrive Capital Partners II, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners II GP, LLC, its general partner
Date:	09/18/2026

Thrive Partners II GP, LLC

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member
Date:	09/18/2026

Thrive Capital Partners III, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners III GP, LLC, its general partner
Date:	09/18/2026

Claremount TW, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners III GP, LLC, its general partner
Date:	09/18/2026

Thrive Partners III GP, LLC

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member
Date:	09/18/2026

Thrive Capital Partners V, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners V GP, LLC, its general partner
Date:	09/18/2026

Claremount V Associates, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners V GP, LLC, its general partner
Date:	09/18/2026

Thrive Partners V GP, LLC

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member
Date:	09/18/2026

Thrive Capital Partners VI Growth, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners VI GP, LLC, its general partner
Date:	09/18/2026

Claremount VI Associates, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners VI GP, LLC, its general partner
Date:	09/18/2026

Thrive Partners VI GP, LLC

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member
Date:	09/18/2026

Thrive Capital Partners VII Growth, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners VII Growth GP, LLC, its general partner
Date:	09/18/2026

Thrive Partners VII Growth GP, LLC

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member
Date:	09/18/2026

Claremount VII Associates, L.P.

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member of Thrive Partners VII GP, LLC, its general partner
Date:	09/18/2026

Thrive Partners VII GP, LLC

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner, Managing Member
Date:	09/18/2026

Joshua Kushner

Signature:	/s/ Joshua Kushner
Name/Title:	Joshua Kushner
Date:	09/18/2026